Cyteir Therapeutics Announces Prioritization of CYT-0851 Development and Extended Cash Runway streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
31.08.2022 - Cyteir Therapeutics, Inc. (“Cyteir”) (Nasdaq: CYT), a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer, today announced that its President and Chief Executive Officer, Markus Renschler, .
Cyteir Therapeutics Reports Second Quarter 2022 Financial Results and Operational Highlights - Sharpening focus on the pipeline extends cash runway into second. | August 8, 2022